Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.82 |
| ▸ | PGR | P06401 | 6/20 | 0.82 |
| ▸ | ABCB11 | O95342 | 5/20 | 0.82 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.82 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.82 |
| ▸ | AR | P10275 | 4/20 | 0.82 |
| ▸ | MEN1 | O00255 | 3/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.82 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.82 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.82 |
| ▸ | MAPT | P10636 | 2/20 | 0.82 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.82 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.82 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.82 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.82 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.82 |
| ▸ | LMNA | P02545 | 5/20 | 0.66 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.66 |
| ▸ | ESR1 | P03372 | 3/20 | 0.66 |
| ▸ | SHBG | P04278 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8853802 | 0.93 | CYP3A4 (0.79) | CYP3A4PGRABCB11CYP2C19NR3C1 | |
| SCHEMBL10624499 | 0.92 | CYP3A4 (0.82) | CYP3A4PGRABCB11CYP2C19NR3C1 | |
| Norethindrone Acetate SCHEMBL14577826 | 0.90 | CYP3A4 (1.00) | CYP3A4PGRABCB11CYP2C19NR3C1 | |
| Norethindrone Acetate SCHEMBL1232662 | 0.90 | CYP3A4 (1.00) | CYP3A4PGRABCB11CYP2C19NR3C1 | |
| Norethindrone Acetate SCHEMBL14360522 | 0.90 | CYP3A4 (1.00) | CYP3A4PGRABCB11CYP2C19NR3C1 | |
| SCHEMBL11291553 | 0.90 | CYP3A4 (0.85) | CYP3A4PGRABCB11CYP2C19NR3C1 | |
| Norethindrone Acetate SCHEMBL11321479 | 0.90 | CYP3A4 (1.00) | CYP3A4PGRABCB11CYP2C19NR3C1 | |
| Norethindrone Acetate SCHEMBL37530 | 0.90 | CYP3A4 (1.00) | CYP3A4PGRABCB11CYP2C19NR3C1 | |
| Norethindrone Acetate SCHEMBL14074495 | 0.90 | CYP3A4 (1.00) | CYP3A4PGRABCB11CYP2C19NR3C1 | |
| SCHEMBL18171759 | 0.90 | CYP3A4 (0.78) | CYP3A4PGRABCB11CYP2C19NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111060638-A | Screening and confirming method for 207 veterinary drugs and additives in animal food | 河南省兽药饲料监察所(河南省畜产品质量监测检验中心) | 2020-04-24 | — | — | CN | claimed |
| CN-108368127-B | Compounds and their use as EP4 receptor antagonists | 武田药品工业株式会社 | 2020-12-11 | — | — | CN | disclosed |
| CN-111060638-A | Screening and confirming method for 207 veterinary drugs and additives in animal food | 河南省兽药饲料监察所(河南省畜产品质量监测检验中心) | 2020-04-24 | — | — | CN | disclosed |
| US-5595759-A | Process for providing therapeutic composition | ALZA CORPORATION (US) | 1997-01-21 | — | — | US | disclosed |
| US-4027019-A | 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method | ORTHO PHARMACEUTICAL CORPORATION (US) | 1977-05-31 | — | — | US | disclosed |